Your browser doesn't support javascript.
loading
UCHL1 acts as a potential oncogene and affects sensitivity of common anti-tumor drugs in lung adenocarcinoma.
Yao, Jianbo; Reyimu, Abdusemer; Sun, Ao; Duoji, Zaxi; Zhou, Wubi; Liang, Song; Hu, Suxia; Wang, Xiang; Dai, Jingjing; Xu, Xiaoguang.
Afiliación
  • Yao J; College of Life Sciences, Anhui Medical University, Hefei, Anhui, 230032, People's Republic of China.
  • Reyimu A; Medical College, Anhui University of Science and Technology, Huainan, Anhui, 232001, People's Republic of China.
  • Sun A; Class 11, Grade 2018, Clinical Medicine, Nanjing Medical University, Nanjing, Jiangsu, 223300, People's Republic of China.
  • Duoji Z; Research Center of High Altitude Medicine, Naqu, Tibet, China, People's Hospital of Naqu Affiliated to Dalian Medical University, Dalian, Tibet, 852000, People's Republic of China.
  • Zhou W; Department of Pathology, The Affiliated Huaian No.1 People's Hospital of Nanjing Medical University, Huaian, Jiangsu, 223300, People's Republic of China.
  • Liang S; Department of Medical Laboratory, Second branch, The Affiliated Huaian No. 1 People's Hospital of Nanjing Medical University, Huaian, Jiangsu, 223300, People's Republic of China.
  • Hu S; Department of Medical Laboratory, Huainan First People's Hospital, The First Affiliated Hospital of Anhui University of Science and Technology, Huainan, Anhui, 232007, People's Republic of China.
  • Wang X; Department of Pediatrics, The Affiliated Huaian No. 1 People's Hospital of Nanjing Medical University, Huaian, Jiangsu, 223300, People's Republic of China. hayywangx@njmu.edu.cn.
  • Dai J; Department of Hematology, The Affiliated Huaian No. 1 People's Hospital of Nanjing Medical University, Huaian, Jiangsu, 223300, People's Republic of China. hayydaijj@njmu.edu.cn.
  • Xu X; Research Center of High Altitude Medicine, Naqu, Tibet, China, People's Hospital of Naqu Affiliated to Dalian Medical University, Dalian, Tibet, 852000, People's Republic of China. xuxg2007@sohu.com.
World J Surg Oncol ; 20(1): 153, 2022 May 11.
Article en En | MEDLINE | ID: mdl-35546675

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Adenocarcinoma / Adenocarcinoma del Pulmón / Neoplasias Pulmonares / Antineoplásicos Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Humans Idioma: En Revista: World J Surg Oncol Año: 2022 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Adenocarcinoma / Adenocarcinoma del Pulmón / Neoplasias Pulmonares / Antineoplásicos Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Humans Idioma: En Revista: World J Surg Oncol Año: 2022 Tipo del documento: Article